Stifel Financial
SLXNW

Stifel Financial’s Silexion Therapeutics Warrant SLXNW Stock Holding History

Stifel Financial’s Portfolio SLXNW Stock Details SLXNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$325 Hold
16,000
– – ﹤0.01% 3624
2025
Q4 		$416 Hold
16,000
– – ﹤0.01% 3565
2025
Q3 		$563 Hold
16,000
– – ﹤0.01% 3531
2025
Q2 		$654 Hold
16,000
– – ﹤0.01% 3462
2025
Q1 		$1.22K Hold
16,000
– – ﹤0.01% 3445
2024
Q4 		$542 Hold
16,000
– – ﹤0.01% 3372
2024
Q3 		$504 Buy
+16,000
New +$926 ﹤0.01% 3361

Other funds holding SLXNW

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
SBLIC
Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.39% 1-Year Est. Return

Stifel Financial's SLXNW Position: Q1 2026 in Review

Stifel Financial held its Silexion Therapeutics Warrant (SLXNW) position steady in Q1 2026 at 16,000 shares worth $325. The position accounts for ﹤0.01% of the portfolio, ranked #3624.

Stifel Financial first reported a position in SLXNW in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.22K in Q1 2025. 19 funds tracked by Wall St. Rank hold SLXNW as of Q1 2026.

  • Stifel Financial held 16,000 shares of Silexion Therapeutics Warrant worth $325 as of Q1 2026.
  • Stifel Financial left its Silexion Therapeutics Warrant share count unchanged in Q1 2026.
  • Silexion Therapeutics Warrant made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #3624 holding.
  • Stifel Financial first reported a position in Silexion Therapeutics Warrant in Q3 2024 and has held it in 7 quarters since.
  • Stifel Financial's Silexion Therapeutics Warrant position peaked at $1.22K in Q1 2025.
  • 19 funds tracked by Wall St. Rank held Silexion Therapeutics Warrant as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.